Pattara Rattanawong MD , Chieh-Ju Chao MD , Anil Sriramoju MD , Cecilia Tagle-Cornell MS , Juan Maria M. Farina MD , Ellen Beirne MBBS , Marlene E. Girardo MS , Laura M. Koepke MSN , Olubadewa A. Fatunde MD, MPH , Nway L. Ko Ko MBBS , Win-Kuang Shen MD
{"title":"Syncope and All-Cause Mortality in Heart Failure: A Propensity Score–Matched Analysis","authors":"Pattara Rattanawong MD , Chieh-Ju Chao MD , Anil Sriramoju MD , Cecilia Tagle-Cornell MS , Juan Maria M. Farina MD , Ellen Beirne MBBS , Marlene E. Girardo MS , Laura M. Koepke MSN , Olubadewa A. Fatunde MD, MPH , Nway L. Ko Ko MBBS , Win-Kuang Shen MD","doi":"10.1016/j.mayocpiqo.2025.100620","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To examine the association between syncope and all-cause mortality in a large cohort of patients with heart failure (HF) with syncope.</div></div><div><h3>Patients and Methods</h3><div>We retrospectively identified a cohort of patients with HF and syncope from January 1, 2010, to December 31, 2015, and matched them in a 1:1 propensity analysis with patients with HF without syncope. A multivariable Cox regression model was used to estimate the association between syncope and the end point, all-cause mortality.</div></div><div><h3>Results</h3><div>During the study period, 3449 patients with HF were diagnosed with syncope (mean ± SD age, 72.8±14.3 years). At 12 months follow-up, syncope was not an independent risk factor of all-cause mortality in overall patients with HF (hazard ratio [HR], 0.98; 95% CI, 0.91-1.04; <em>P</em>=.467), HF with preserved ejection fraction (EF) (HR, 1.02; 95% CI, 0.93-1.11; <em>P</em>=.686), HF with mid-range EF (HR, 0.92; 95% CI, 0.73-1.16; <em>P</em>=.494), or HF with reduced EF (HR, 0.94; 95% CI, 0.83-1.06; <em>P</em>=284). In the subgroup of those with cardiac implantable electronic devices, syncope significantly increased the risk of all-cause mortality in HF with reduced EF (HR, 1.28; 95% CI, 1.01-1.62; <em>P</em>=.038).</div></div><div><h3>Conclusion</h3><div>Syncope was not an independent risk of all-cause mortality for patients with HF but significantly predicted the all-cause mortality in the subgroup of patients with heart failure reduced EF with cardiac implantable electronic devices.</div></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"9 3","pages":"Article 100620"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mayo Clinic proceedings. Innovations, quality & outcomes","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2542454825000311","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
To examine the association between syncope and all-cause mortality in a large cohort of patients with heart failure (HF) with syncope.
Patients and Methods
We retrospectively identified a cohort of patients with HF and syncope from January 1, 2010, to December 31, 2015, and matched them in a 1:1 propensity analysis with patients with HF without syncope. A multivariable Cox regression model was used to estimate the association between syncope and the end point, all-cause mortality.
Results
During the study period, 3449 patients with HF were diagnosed with syncope (mean ± SD age, 72.8±14.3 years). At 12 months follow-up, syncope was not an independent risk factor of all-cause mortality in overall patients with HF (hazard ratio [HR], 0.98; 95% CI, 0.91-1.04; P=.467), HF with preserved ejection fraction (EF) (HR, 1.02; 95% CI, 0.93-1.11; P=.686), HF with mid-range EF (HR, 0.92; 95% CI, 0.73-1.16; P=.494), or HF with reduced EF (HR, 0.94; 95% CI, 0.83-1.06; P=284). In the subgroup of those with cardiac implantable electronic devices, syncope significantly increased the risk of all-cause mortality in HF with reduced EF (HR, 1.28; 95% CI, 1.01-1.62; P=.038).
Conclusion
Syncope was not an independent risk of all-cause mortality for patients with HF but significantly predicted the all-cause mortality in the subgroup of patients with heart failure reduced EF with cardiac implantable electronic devices.